Searched for
DIABETES MELLITUS TYPE 2
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Weight-loss drugs trim UK food bills by $1 billionHouseholds with at least one user of GLP-1 weight-loss drugs bought 299 million fewer food items in the year after adoption of the medicati...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- Cabinet clears Rs 2,534 crore office, housing projects in AmaravatiThe Union Cabinet has approved two major infrastructure projects in Amaravati. These include an office complex and a residential township f...
- Practo's CPTO shares how AI is changing his daily lifePracto's Srijesh K highlights the addictive nature of AI tools for building and testing. He shares how AI assists in personal tasks, from f...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
- Heat waves demand more than just water for proper hydration; electrolytes intake necessary: ExpertsHealth experts warn that during heat waves, water alone is not enough for hydration. Excessive sweating depletes essential electrolytes lik...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Bloating, constipation, poor digestion? Oxford-certified celebrity nutritionist shares 5 common superfoods you can easily find in your grocery storeDigestive issues like bloating and constipation are common. Mumbai-based nutritionist Suman Agarwal highlights five superfoods for better g...
- The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- Homeopathy doctor shares simple tips to reduce facial and belly fat; says your future self will thank youHealth experts warn that facial puffiness and belly fat, particularly visceral fat, are serious health indicators. Dr. Sayajirao Gaikwad em...
- Stocks in news: ITC, Nykaa, Lenskart, Ola Electric, IndusInd BankMarkets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downsid...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
- Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in CanadaDr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providin...
Load More
